Royce & Associates LP Evolus, Inc. Transaction History

Royce & Associates LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$3.53 - $6.17 $451,840 - $789,760	-128,000 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$13.19 - $28.36 $1.32 Million - $2.84 Million	100,000 Added 357.14%	128,000 $1.87 Million
Q1 2019 May 09, 2019	BUY	$12.43 - $28.91 $348,040 - $809,480	28,000 New	28,000 $632,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.